Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 3
1999 4
2000 8
2001 16
2002 12
2003 16
2004 20
2005 20
2006 17
2007 28
2008 19
2009 24
2010 20
2011 17
2012 22
2013 25
2014 16
2015 16
2016 15
2017 11
2018 13
2019 13
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

327 results
Results by year
Filters applied: . Clear all
Page 1
ASCA and ANCA among Bedouin Arabs with inflammatory bowel disease, the frequency and phenotype correlation.
Abu-Freha N, Badarna W, Sigal-Batikoff I, Abu Tailakh M, Etzion O, Elkrinawi J, Segal A, Mushkalo A, Fich A. Abu-Freha N, et al. BMC Gastroenterol. 2018 Oct 20;18(1):153. doi: 10.1186/s12876-018-0884-x. BMC Gastroenterol. 2018. PMID: 30342474 Free PMC article.
BACKGROUND: Serological markers used for diagnostic purposes and disease stratification in inflammatory bowel disease. We aimed to investigate the frequency of ASCA and ANCA among Arab Bedouin IBD patients and its relationship to disease phenotype and …
BACKGROUND: Serological markers used for diagnostic purposes and disease stratification in inflammatory bowel disease. We aime …
IBD Serology and Disease Outcomes in African Americans With Crohn's Disease.
Bertha M, Vasantharoopan A, Kumar A, Bruce BB, Prince J, Hofmekler T, Okou D, Chopra P, Wang G, Sauer C, Landers CJ, Hussain SZ, Cross RK, Baldassano RN, Kappelman MD, Katz J, Alexander JS, Kirschner BS, Moulton DE, Osuntokun BO, Patel A, Saeed S, Klapproth JA, Dhere TA, Dubinsky MC, McGovern D, Kugathasan S. Bertha M, et al. Inflamm Bowel Dis. 2017 Dec 19;24(1):209-216. doi: 10.1093/ibd/izx021. Inflamm Bowel Dis. 2017. PMID: 29272484 Free PMC article.
BACKGROUNDS: Recent studies have identified the role of serologic markers in characterizing disease phenotype, location, complications, and severity among Northern Europeans (NE) with Crohn's disease (CD). ...On multivariable analysis, both IgG ASCA an …
BACKGROUNDS: Recent studies have identified the role of serologic markers in characterizing disease phenotype, location, complication …
ASCA, ANCA, ALCA and Many More: Are They Useful in the Diagnosis of Inflammatory Bowel Disease?
Zhou G, Song Y, Yang W, Guo Y, Fang L, Chen Y, Liu Z. Zhou G, et al. Dig Dis. 2016;34(1-2):90-7. doi: 10.1159/000442934. Epub 2016 Mar 16. Dig Dis. 2016. PMID: 26982193 Review.
Moreover, they have been demonstrated to be useful in distinguishing patients with Crohn's disease (CD) from those with ulcerative colitis (UC). ...CONCLUSIONS: Currently, the most important utility of serological biomarkers is to evaluate the aggressive risks of …
Moreover, they have been demonstrated to be useful in distinguishing patients with Crohn's disease (CD) from those with ulcera …
Differential diagnosis of Crohn's disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae.
Duman AE, Hülagü S, Çelebi A, Korkmaz U, Musul MM, Şentürk Ö, Şirin G, Yılmaz H, Koç DÖ, Dindar G, Öztürkler M, Bozkurt N, Kır HM. Duman AE, et al. Turk J Gastroenterol. 2019 Jan;30(1):21-27. doi: 10.5152/tjg.2018.18135. Turk J Gastroenterol. 2019. PMID: 30465525 Free PMC article.
BACKGROUND/AIMS: Glycoprotein 2 (GP2), the major autoantigen of Crohn's disease (CD)-specific pancreatic autoantibodies, is reportedly correlated with several characteristics of CD. ...As ASCA seropositivity is associated with a more complicated disease
BACKGROUND/AIMS: Glycoprotein 2 (GP2), the major autoantigen of Crohn's disease (CD)-specific pancreatic autoantibodies, is re …
pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease.
Mokrowiecka A, Gasiorowska A, Malecka-Panas E. Mokrowiecka A, et al. Hepatogastroenterology. 2007 Jul-Aug;54(77):1443-8. Hepatogastroenterology. 2007. PMID: 17708273
BACKGROUND/AIMS: The measurement of perinuclear antineutrophil cytoplasmic (pANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) has recently been suggested as a valuable and noninvasive diagnostic approach in the differentiation of ulcerative colitis (UC), Crohn
BACKGROUND/AIMS: The measurement of perinuclear antineutrophil cytoplasmic (pANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA
pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.
Birimberg-Schwartz L, Wilson DC, Kolho KL, Karolewska-Bochenek K, Afzal NA, Spray C, Romano C, Lionetti P, Hauer AC, Martinez-Vinson C, Veres G, Escher JC, Turner D; paediatric IBD Porto group of ESPGHAN. Birimberg-Schwartz L, et al. Inflamm Bowel Dis. 2016 Aug;22(8):1908-14. doi: 10.1097/MIB.0000000000000784. Inflamm Bowel Dis. 2016. PMID: 27135480
INTRODUCTION: No study to date has evaluated perinuclear antineutrophil cytoplasmic antibody (pANCA) and anti-Saccharomyces cerevisiae antibody (ASCA) in pediatric inflammatory bowel disease-unclassified (IBDU) as compared with Crohn's colitis (CC) and ulcera …
INTRODUCTION: No study to date has evaluated perinuclear antineutrophil cytoplasmic antibody (pANCA) and anti-Saccharomyces cerevisiae antib …
Assessment of Fecal ASCA Measurement as a Biomarker of Crohn Disease in Pediatric Patients.
Tang V, Valim C, Moman R, Richman A, Zhou J, Ramgopal V, Albert R, Boone JH, Rufo PA. Tang V, et al. J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):248-253. doi: 10.1097/MPG.0000000000001244. J Pediatr Gastroenterol Nutr. 2017. PMID: 27111346 Clinical Trial.
OBJECTIVES: A simple and reliable biomarker for Crohn disease (CD) would be a valuable clinical tool. We hypothesized that anti-Saccharomyces cerevisiae antibody (ASCA) may be present in the stool of patients with CD. Accordingly, we measured ASCA in t …
OBJECTIVES: A simple and reliable biomarker for Crohn disease (CD) would be a valuable clinical tool. We hypothesized that ant …
Diagnostic and clinical significance of Crohn's disease-specific pancreatic anti-GP2 and anti-CUZD1 antibodies.
Pavlidis P, Komorowski L, Teegen B, Liaskos C, Koutsoumpas AL, Smyk DS, Perricone C, Mytilinaiou MG, Stocker W, Forbes A, Bogdanos DP. Pavlidis P, et al. Clin Chem Lab Med. 2016 Feb;54(2):249-56. doi: 10.1515/cclm-2015-0376. Clin Chem Lab Med. 2016. PMID: 26351932
BACKGROUND: Pancreatic autoantibodies (PAB) targeting GP2 and CUZD1 are Crohn's disease (CrD)-markers. The clinical significance of anti-GP2 antibodies has been assessed, but that of anti-CUZD1 remains elusive. ...Also, anti-GP2 IgG positive CrD patients had younger …
BACKGROUND: Pancreatic autoantibodies (PAB) targeting GP2 and CUZD1 are Crohn's disease (CrD)-markers. The clinical significan …
Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn's disease.
Duarte-Silva M, Afonso PC, de Souza PR, Peghini BC, Rodrigues-Júnior V, de Barros Cardoso CR. Duarte-Silva M, et al. Autoimmunity. 2019 Feb;52(1):37-47. doi: 10.1080/08916934.2019.1588889. Epub 2019 Mar 19. Autoimmunity. 2019. PMID: 30884988 Clinical Trial.
A clear correlation exists between microbiota and the dysregulation of the immune response in Inflammatory Bowel Diseases (IBD), which comprise Crohn's disease (CD) and ulcerative colitis (UC). ...Thus, here we aimed to quantify IgA and IgG specific to S. cerevisiae …
A clear correlation exists between microbiota and the dysregulation of the immune response in Inflammatory Bowel Diseases (IBD), which compr …
Candida albicans colonization and ASCA in familial Crohn's disease.
Standaert-Vitse A, Sendid B, Joossens M, François N, Vandewalle-El Khoury P, Branche J, Van Kruiningen H, Jouault T, Rutgeerts P, Gower-Rousseau C, Libersa C, Neut C, Broly F, Chamaillard M, Vermeire S, Poulain D, Colombel JF. Standaert-Vitse A, et al. Am J Gastroenterol. 2009 Jul;104(7):1745-53. doi: 10.1038/ajg.2009.225. Epub 2009 May 26. Am J Gastroenterol. 2009. PMID: 19471251
OBJECTIVES: Anti-Saccharomyces cerevisiae antibodies (ASCAs) are present in 50-60% of patients with Crohn's disease (CD) and in 20-25% of their healthy relatives (HRs). ...In CD, a subsequent alteration in sensing C. albicans colonization could occur with disease
OBJECTIVES: Anti-Saccharomyces cerevisiae antibodies (ASCAs) are present in 50-60% of patients with Crohn's disease (CD) and i …
327 results
Jump to page
Feedback